Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$11.9M Buy
161,038
+7,359
+5% +$554K 0.38% 50
2020
Q1
$11.3M Sell
153,679
-2,267
-1% -$178K 0.45% 32
2019
Q4
$13.6M Buy
155,946
+5,161
+3% +$424K 0.42% 36
2019
Q3
$12.1M Sell
150,785
-18,676
-11% -$1.5M 0.42% 37
2019
Q2
$13.6M Buy
169,461
+29,123
+21% +$2.23M 0.5% 29
2019
Q1
$11.2M Sell
140,338
-40,105
-22% -$3M 0.42% 41
2018
Q4
$13.2M Sell
180,443
-11,148
-6% -$787K 0.58% 26
2018
Q3
$13M Sell
191,591
-24,901
-12% -$1.59M 0.47% 28
2018
Q2
$12.6M Buy
216,492
+27,674
+15% +$1.56M 0.48% 28
2018
Q1
$9.83M Buy
188,818
+35,223
+23% +$1.9M 0.39% 43
2017
Q4
$8.26M Buy
153,595
+2,821
+2% +$156K 0.32% 56
2017
Q3
$9.22M Buy
150,774
+3,367
+2% +$204K 0.38% 43
2017
Q2
$9.03M Buy
147,407
+14,413
+11% +$877K 0.42% 39
2017
Q1
$8.07M Buy
132,994
+5,197
+4% +$315K 0.38% 40
2016
Q4
$7.24M Buy
127,797
+120,017
+1,543% +$7.02M 0.4% 42
2016
Q3
$467K Buy
+7,780
New +$455K 0.05% 206

Other funds holding MRK

Brinker Capital's MRK Position: Q2 2020 in Review

Brinker Capital increased its Merck (MRK) stake by 4.8% in Q2 2020, buying an estimated $554K and bringing the position to 161,038 shares worth $11.9M. The position accounts for 0.38% of the portfolio, ranked #50.

Brinker Capital first reported a position in MRK in Q3 2016 and has held it in 16 quarters since. The position peaked at $13.6M in Q2 2019. 2,496 funds tracked by Wall St. Rank hold MRK as of Q2 2020.

  • Brinker Capital held 161,038 shares of Merck worth $11.9M as of Q2 2020.
  • Brinker Capital bought 7,359 Merck shares in Q2 2020, an estimated $554K.
  • Merck made up 0.38% of Brinker Capital's portfolio in Q2 2020, its #50 holding.
  • Brinker Capital first reported a position in Merck in Q3 2016 and has held it in 16 quarters since.
  • Brinker Capital's Merck position peaked at $13.6M in Q2 2019.
  • 2,496 funds tracked by Wall St. Rank held Merck as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.